Matthew A. Powell

Also affiliated with St Louis Community College, University of British Columbia, Washington University in St. Louis, University of Missouri–St. Louis, Duke Medical Center, National Cancer Institute, NRG Oncology, Université de Montréal

MedicineBiochemistry, Genetics and Molecular BiologyImmunology and Microbiology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 18 papers. Top paper: “Long-Term Outcomes of Cervical Cancer Patients Treated With Definitive Chemoradiation Following a Complete Metabolic Response”.

Long-Term Outcomes of Cervical Cancer Patients Treated With Definitive Chemoradiation Following a Complete Metabolic Response

Clinical Oncology(2021)10.1016/j.clon.2021.01.010

N/A

1.2DataRank · unranked

13 citations

Farrokh Dehdashti, L. Stewart Massad, Premal H. Thaker, Matthew A. Powell, David G. Mutch +5 more

The presence of an endometrioid component does not alter the clinicopathologic profile or survival of patients with uterine serous cancer: A gynecologic oncology group (GOG/NRG) study of 934 women

Gynecologic Oncology(2021)10.1016/j.ygyno.2020.12.040

N/A

0.941DataRank · unranked

26 citations

Wei Deng, Richard J. Zaino, Matthew A. Powell, Camille C. Gunderson, Casey Cosgrove +15 more

Mixed clear cell/endometrioid and clear cell/serous carcinoma of the uterus are clinicopathologically similar to pure clear cell carcinoma: An NRG Oncology/Gynecologic Oncology Group (GOG-210) study of 311 women

Gynecologic Oncology(2023)10.1016/j.ygyno.2023.08.005

N/A

0.360DataRank · unranked

10 citations

Wei Deng, Richard J. Zaino, Matthew A. Powell, Camille Gunderson Jackson, Casey Cosgrove +14 more

Radiation therapy for vaginal and perirectal lesions in recurrent ovarian cancer

Gynecologic Oncology Reports(2021)10.1016/j.gore.2021.100808

N/A

0DataRank · unranked

3 citations

Jennifer Stanley, Michael Toboni, Julie K. Schwarz, F. Zhang, Andrea R. Hagemann +8 more

High visceral fat to subcutaneous fat ratios portend a poor prognosis in patients with advanced endometrial cancer

Gynecologic Oncology(2022)10.1016/j.ygyno.2022.09.011

N/A

0DataRank · unranked

12 citations

Mary M. Mullen, Rehan Nizamuddin, Jonathan H. Stein, Lindsay M. Kuroki, Katherine C. Fuh +8 more

RAD51 Foci as a Biomarker Predictive of Platinum Chemotherapy Response in Ovarian Cancer

Clinical Cancer Research(2023)10.1158/1078-0432.ccr-22-3335

N/A

0DataRank · unranked

65 citations

Lillian N. van Biljon, Mark C. Valentine, Alba Llop‐Guevara, Emily Graham, Bisiayo Fashemi +18 more

Stromal DDR2 Promotes Ovarian Cancer Metastasis through Regulation of Metabolism and Secretion of Extracellular Matrix Proteins

Molecular Cancer Research(2023)10.1158/1541-7786.mcr-23-0347

N/A

0DataRank · unranked

22 citations

Molly M. Greenwade, Elizabeth Stock, Elena Lomonosova, Kevin Cho, Whitney R. Grither +17 more

Characterization of adnexal lesions using photoacoustic imaging to improve sonographic O‐RADS risk assessment

Ultrasound in Obstetrics and Gynecology(2023)10.1002/uog.27452

N/A

0DataRank · unranked

3 citations

Hongbo Luo, William D. Middleton, Malak Itani, Ian S. Hagemann, Andrea R. Hagemann +8 more

#267 Quality-adjusted time without symptoms of disease or toxicity in patients with primary advanced or recurrent endometrial cancer treated with dostarlimab plus carboplatin-paclitaxel versus carboplatin-paclitaxel in the ENGOT-EN6/GOG-3031/RUBY trial

International Journal of Gynecological Cancer(2023)10.1136/ijgc-2023-esgo.13

N/A

0DataRank · unranked

2 citations

Line Bjørge, Robert L. Coleman, Oleksandr Zub, Eirwen M. Miller, Roberto Angioli +15 more

Neoplastic and blood-based biomarkers of response in patients with advanced endometrial cancer: Results from NRG GY012.

Journal of Clinical Oncology(2023)10.1200/jco.2023.41.16_suppl.5525

N/A

0DataRank · unranked

1 citations

Andrew B. Nixon, Danielle Enserro, David Bender, B.J. Rimel, Matthew A. Powell +12 more

Racial, ethnic and country of origin disparities in aggressive endometrial cancer histologic subtypes

Gynecologic Oncology(2024)10.1016/j.ygyno.2024.01.009

N/A

0DataRank · unranked

9 citations

Chunqiao Tian, Yovanni Casablanca, Nicholas W. Bateman, Suzanne Jokajtys, Calen Kucera +20 more

The novel drug candidate S2/IAPinh improves survival in models of pancreatic and ovarian cancer

Scientific Reports(2024)10.1038/s41598-024-56928-z

N/A

0DataRank · unranked

2 citations

Suwanna Vangveravong, Rony Takchi, Qingqing Gong, S. Peter Goedegebuure, Hervé Tiriac +5 more

Phospho-RPA2 predicts response to platinum and PARP inhibitors in homologous recombination–proficient ovarian cancer

Journal of Clinical Investigation(2025)10.1172/jci189511

N/A

0DataRank · unranked

7 citations

Amanda Compadre, Rebecca Drexler, Megan Loeb, Kevin Rodriguez, Joshua Brill +22 more

Vascular graph network for ovarian lesion classification using optical-resolution photoacoustic microscopy

Photoacoustics(2025)10.1016/j.pacs.2025.100794

N/A

0DataRank · unranked

2 citations

L. Wang, Ian S. Hagemann, Lindsay M. Kuroki, Brooke E. Sanders, Andrea R. Hagemann +4 more

Effect on response to neoadjuvant chemotherapy in high-grade serous ovarian cancer by inhibiting the GAS6/AXL pathway and inducing homologous recombination deficiency.

Journal of Clinical Oncology(2020)10.1200/jco.2020.38.15_suppl.6080

N/A

0DataRank · unranked

0 citations

Elena Lomonosova, Michael Toboni, Hollie Noia, Danny Wilke, Alyssa Oplt +9 more

Targeting RAD52 overcomes PARP inhibitor resistance in preclinical Brca2 -deficient ovarian cancer model

bioRxiv (Cold Spring Harbor Laboratory)(2025)10.1101/2025.09.24.678351

N/A

0DataRank · unranked

0 citations

Vijayalaxmi Gupta, Bisiayo Fashemi, Moreniola Akande, Elizabeth Babu, Prasanth Thuthika +17 more

Surgical-pathological findings in type 1 and 2 endometrial cancer: An NRG Oncology/Gynecologic Oncology Group study on GOG-210 protocol

UNC Libraries(2020)10.17615/5jcw-ca69

N/A

0DataRank · unranked

0 citations

David S. Miller, Steven Waggoner, Robert P. Edwards, Saketh R. Guntupalli, Matthew A. Powell +13 more

Impact of employment and insurance status on distress in gynecologic oncology patients

Gynecologic Oncology(2021)10.1016/j.ygyno.2021.01.038

N/A

0DataRank · unranked

10 citations

David H. Morris, Molly M. Greenwade, Megan Landon, Andrea R. Hagemann, Premal H. Thaker +8 more